|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 132.66 USD | -2.31% |
|
-2.45% | -6.47% |
| Capitalization | 1.35TCr 1.16TCr 1.08TCr 1.01TCr 1.88TCr 1,22000Cr 2.02TCr 12TCr 4.88TCr 58TCr 5.08TCr 4.97TCr 2,14000Cr | P/E ratio 2025 * |
27x | P/E ratio 2026 * | 19.4x |
|---|---|---|---|---|---|
| Enterprise value | 1.2TCr 1.03TCr 953.91Cr 888.39Cr 1.66TCr 1,07800Cr 1.78TCr 11TCr 4.31TCr 52TCr 4.49TCr 4.39TCr 1,89100Cr | EV / Sales 2025 * |
4.19x | EV / Sales 2026 * | 3.31x |
| Free-Float |
98.7% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Neurocrine Biosciences, Inc.
| 1 day | -2.31% | ||
| 1 week | -2.45% | ||
| Current month | -6.47% | ||
| 1 month | -13.18% | ||
| 3 months | -3.41% | ||
| 6 months | -1.83% | ||
| Current year | -6.47% |
| 1 week | 132.16 |  | 142.16 |
| 1 month | 132.16 | | 155.55 |
| Current year | 132.16 | | 142.16 |
| 1 year | 84.23 | | 160.18 |
| 3 years | 84.23 | | 160.18 |
| 5 years | 71.88 | | 160.18 |
| 10 years | 31.25 | | 160.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kyle Gano
CEO | Chief Executive Officer | 53 | 11/10/2024 |
| Director of Finance/CFO | 47 | 01/11/2017 | |
Sanjay Keswani
CTO | Chief Tech/Sci/R&D Officer | 56 | 02/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Gorman
BRD | Director/Board Member | 68 | 01/01/2008 |
Richard Pops
BRD | Director/Board Member | 64 | 01/04/1998 |
| Chairman | 78 | 01/05/2011 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -3.27% | 13.65% | 303 M€ | |
| 0.00% | 3.81% | 1 M€ | |
| 0.00% | 1.85% | 5 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.31% | -2.45% | -7.25% | +21.10% | 1.35TCr | |
| +1.64% | +0.06% | +35.14% | +199.94% | 95TCr | |
| +2.61% | +1.14% | +47.63% | +19.92% | 49TCr | |
| -0.02% | -4.04% | +25.62% | +40.00% | 39TCr | |
| +0.50% | +5.22% | +29.29% | +18.53% | 36TCr | |
| -0.68% | +5.50% | +30.47% | +23.34% | 30TCr | |
| -1.21% | +2.57% | +10.02% | -1.69% | 27TCr | |
| -0.18% | +4.92% | +25.39% | +35.33% | 27TCr | |
| -0.62% | +9.33% | -38.17% | -17.02% | 26TCr | |
| -0.17% | +1.50% | +20.49% | +20.16% | 18TCr | |
| Average | -0.17% | +2.09% | +17.86% | +35.96% | 34.93TCr | |
| Weighted average by Cap. | +0.23% | +1.46% | +25.66% | +68.12% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 285.52Cr 244.72Cr 227.68Cr 212.04Cr 396.2Cr 26TCr 425.5Cr 2.61TCr 1.03TCr 12TCr 1.07TCr 1.05TCr 45TCr | 339.2Cr 290.73Cr 270.48Cr 251.9Cr 470.68Cr 31TCr 505.49Cr 3.1TCr 1.22TCr 15TCr 1.27TCr 1.25TCr 54TCr |
| Net income | 51Cr 44Cr 41Cr 38Cr 71Cr 4.59TCr 76Cr 466.31Cr 183.93Cr 2.2TCr 191.23Cr 187.26Cr 8.06TCr | 70Cr 60Cr 56Cr 52Cr 97Cr 6.32TCr 104.61Cr 641.89Cr 253.19Cr 3.03TCr 263.24Cr 257.77Cr 11TCr |
| Net Debt | -157.65Cr -135.12Cr -125.71Cr -117.08Cr -218.76Cr -14TCr -234.93Cr -1.44TCr -568.61Cr -6.8TCr -591.18Cr -578.9Cr -25TCr | -231.55Cr -198.46Cr -184.64Cr -171.95Cr -321.3Cr -21TCr -345.06Cr -2.12TCr -835.14Cr -9.98TCr -868.3Cr -850.26Cr -37TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/26/09 | 135.79 $ | +0.16% | 14,19,297 |
| 08/26/08 | 135.57 $ | -3.59% | 15,68,583 |
| 07/26/07 | 140.62 $ | +2.38% | 12,89,088 |
| 06/26/06 | 137.35 $ | +1.00% | 11,18,400 |
Delayed Quote Nasdaq, January 13, 2026 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NBIX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition